DekaBank Deutsche Girozentrale trimmed its stake in shares of AMETEK, Inc. (NYSE:AME) by 7.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 186,020 shares of the technology company’s stock after selling 15,576 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in AMETEK were worth $22,046,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Regent Peak Wealth Advisors LLC bought a new position in AMETEK in the 4th quarter worth about $26,000. International Assets Investment Management LLC bought a new position in AMETEK in the 4th quarter worth about $27,000. Fieldpoint Private Securities LLC bought a new position in AMETEK in the 4th quarter worth about $30,000. CX Institutional increased its stake in AMETEK by 46.6% in the 4th quarter. CX Institutional now owns 302 shares of the technology company’s stock worth $37,000 after acquiring an additional 96 shares during the last quarter. Finally, Vantage Consulting Group Inc bought a new position in AMETEK in the 4th quarter worth about $40,000. Institutional investors and hedge funds own 85.66% of the company’s stock.
In other news, Director Anthony James Conti sold 740 shares of the stock in a transaction that occurred on Thursday, March 25th. The stock was sold at an average price of $121.43, for a total value of $89,858.20. Following the completion of the transaction, the director now owns 25,538 shares of the company’s stock, valued at approximately $3,101,079.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider John Wesley Hardin sold 4,148 shares of the stock in a transaction that occurred on Tuesday, March 16th. The stock was sold at an average price of $124.00, for a total value of $514,352.00. Following the completion of the transaction, the insider now directly owns 56,085 shares of the company’s stock, valued at approximately $6,954,540. The disclosure for this sale can be found here. Insiders sold a total of 37,128 shares of company stock valued at $4,670,688 in the last three months. Corporate insiders own 0.74% of the company’s stock.
Shares of AME stock opened at $129.55 on Thursday. The stock has a market capitalization of $29.90 billion, a PE ratio of 34.27, a P/E/G ratio of 3.73 and a beta of 1.36. AMETEK, Inc. has a 1-year low of $73.11 and a 1-year high of $131.79. The business has a 50-day moving average of $122.98 and a 200 day moving average of $115.98. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.88 and a quick ratio of 1.47.
AMETEK (NYSE:AME) last released its quarterly earnings data on Wednesday, February 3rd. The technology company reported $1.08 earnings per share for the quarter, topping the consensus estimate of $1.03 by $0.05. AMETEK had a return on equity of 16.29% and a net margin of 18.77%. The business had revenue of $1.20 billion during the quarter, compared to analysts’ expectations of $1.20 billion. During the same quarter last year, the business posted $1.08 EPS. The business’s revenue was down 8.1% on a year-over-year basis. Analysts anticipate that AMETEK, Inc. will post 3.9 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, March 31st. Stockholders of record on Monday, March 15th were given a $0.20 dividend. The ex-dividend date was Friday, March 12th. This represents a $0.80 annualized dividend and a dividend yield of 0.62%. This is a positive change from AMETEK’s previous quarterly dividend of $0.18. AMETEK’s dividend payout ratio is currently 19.09%.
AMETEK Company Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.
Further Reading: Compound Interest and Why It Matters When Investing
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.